Physician profile
Mark E Blankenship
NPI 1861492191
$3,114.42
in general payments reported to CMS, 2019-2025
13 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,579 · 2020: $27.85 · 2021: $72.65 · 2022: $142 · 2023: $101 · 2024: $64.48 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $293.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,524.46 | 2019 | |
| Medtronic, INC. | $270.42 | 2021-2025 | Interstim |
| Thd America, INC. | $64.67 | 2020-2024 | |
| Smith+Nephew, INC. | $46.63 | 2025 | Grafix Pl, Stravix |
| Medtronic USA, INC. | $41.59 | 2019-2020 | |
| Axonics, INC. | $34.57 | 2021-2023 | Axonics |
| Portola Pharmaceuticals, LLC | $24.31 | 2019 | |
| Baxter Healthcare | $22.63 | 2022 | |
| Lsi Solutions INC | $22.46 | 2025 | Running Device, Ti-Knot |
| Solventum Corporation | $21.15 | 2025 | Activ.A.C., V.A.C. Granufoam |
| Becton, Dickinson and Company | $15.05 | 2024 | Phasix Mesh |
| Novo Nordisk INC | $14.62 | 2021 | |
| Ethicon US, LLC | $11.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Blankenship listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.